Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.7 USD | +5.59% | +3.03% | -5.12% |
Financials (USD)
Sales 2022 | 42.01M | Sales 2023 | 39.55M | Capitalization | 26.7M |
---|---|---|---|---|---|
Net income 2022 | -5M | Net income 2023 | -6M | EV / Sales 2022 | 0.8 x |
Net Debt 2022 | 1.2M | Net Debt 2023 | 107K | EV / Sales 2023 | 0.68 x |
P/E ratio 2022 |
-5.88
x | P/E ratio 2023 |
-4.07
x | Employees | 91 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 55.94% |
Latest transcript on Cumberland Pharmaceuticals Inc.
1 day | +5.59% | ||
1 week | +3.03% | ||
Current month | +1.19% | ||
1 month | -0.58% | ||
3 months | -10.53% | ||
6 months | -16.26% | ||
Current year | -5.12% |
Managers | Title | Age | Since |
---|---|---|---|
A. Kazimi
CEO | Chief Executive Officer | 65 | 99-01-06 |
John Hamm
DFI | Director of Finance/CFO | 67 | 18-12-31 |
James Herman
CMP | Compliance Officer | 67 | 02-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Martin Brown
BRD | Director/Board Member | 59 | 22-07-14 |
A. Kazimi
CEO | Chief Executive Officer | 65 | 99-01-06 |
Ken Krogulski
BRD | Director/Board Member | 66 | 17-01-17 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 1.7 | +5.59% | 742 |
24-04-24 | 1.61 | -1.83% | 4,498 |
24-04-23 | 1.64 | +1.23% | 6,778 |
24-04-22 | 1.62 | +1.25% | 2,182 |
24-04-19 | 1.6 | -3.03% | 786 |
Delayed Quote Nasdaq, April 25, 2024 at 04:30 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-5.12% | 24.1M | |
+20.44% | 21.89B | |
+12.82% | 14.45B | |
+13.26% | 13.63B | |
+38.09% | 11.49B | |
-8.59% | 6.85B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+6.35% | 5.06B | |
-5.36% | 4.66B |
- Stock Market
- Equities
- CPIX Stock